Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning

Lidocaine 4% Topical Anesthetic Cream

Date of Recall

2022-06-30

CPSC Release Number

22-754

Manufactured In

United States

Units

About 9,000

Manufacturer

Mohnark Pharmaceuticals Inc., of Davie, Fla.

Sold By

Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.

Problem/Hazard

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

Injuries/Incidents

None reported

Description

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

Remedy

Refund

No comments have been posted.
Be the first to add a comment!